NanoViricides Inc. (NNVC)

[JG36]

Bingo --

Quote:The only other supplier of cash is stockholders. By tripling its share count a drug developer can raise the cash to do its own phase 3 trials.

Note the use of the indefinite article. I said "a drug developer", not "Nanoviricides". My point was simply that no matter how expensive phase III tests were a company could in principle pay for them by diluting its shares sufficiently, at a cost to its existing shareholders. This statement was made in the context of debating the cost of phase III trials for Flucide, but nowhere in that statement was I making a claim about what the cost of Flucide phase III trials would be, or how many shares NNVC would have to sell to pay for them.

Quote:I never said that FDA approval was required for doing trials in Australia.


You have a short memory. You deleted your post after I corrected you.

I never said that, so you didn't "correct" me, and I never deleted any of my posts.